Oral Microbiota Taxa and Pri-miRNA Expression in Bipolar Disorder: A Case–Control Study

Diego Primavera
First
Conceptualization
;
Mauro Giovanni Carta
Resources
;
Massimo Tusconi
Formal Analysis
;
Goce Kalcev;Laura Atzori;Caterina Ferreli;Cinzia Casu;Sara Fais;Germano Orru
Methodology
;
Alessandra Scano
Last
Conceptualization
2025-01-01

Abstract

Background/Objectives: Emerging evidence suggests a role for oral microbiota in mood disorders, particularly bipolar disorder (BD), complementing established links between gut dysbiosis and psychiatric symptoms. This study investigates the composition of oral microbial taxa and the expression of inflammation-related pri-miRNAs (146a and 155) in individuals with BD, aiming to explore their potential as biomarkers in the oral–gut–brain axis. Methods: A matched case–control design was implemented, recruiting 25 BD patients and 46 controls matched by age and sex. Salivary samples were collected, and microbial profiling was conducted via real-time qPCR targeting major bacterial phyla and genera. Pri-miRNA 146a and 155 expression was evaluated through RT-qPCR using validated primers. Statistical comparisons between groups were performed using Fisher’s exact test and non-parametric tests for continuous variables. Results: Microbial analysis revealed significant reductions (p < 0.01) in α-Proteobacteria, γ-Proteobacteria, and Actinobacteria in BD patients versus controls. A shift toward a higher Firmicutes/Bacteroidetes ratio was observed in the BD cohort, suggesting differences in the oral biotic status between the two groups. However, pri-miRNA 146a and 155 expression levels did not differ significantly between the groups and exhibited high inter-individual variability. Conclusions: The findings indicate that oral microbiota composition differs in BD patients, potentially influencing systemic homeostasis through interactions with gut microbial communities and SCFA pathways. These findings should be interpreted as preliminary and hypothesis-generating given the modest sample size. While pri-miRNAs 146a and 155 did not distinguish BD status, the observed microbial taxa alterations should be regarded as exploratory and hypothesis-generating. Larger, longitudinal studies are required to clarify their potential role in BD pathogenesis and risk assessment.
2025
Inglese
15
10
1355
1
18
18
https://www.mdpi.com/2218-273X/15/10/1355
Esperti anonimi
internazionale
scientifica
Bipolar disorders; Oal microbiome; Pri-miRNA 155; Pri-miRNA 146a; Biomarkers
Goal 3: Good health and well-being
Primavera, Diego; Carta, Mauro; Tusconi, Massimo; Kalcev, Goce; Atzori, Laura; Ferreli, Caterina; Romero Ramirez, Rober; Peddio, Letizia; Casu, Cinzia ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
12
open
Files in This Item:
File Size Format  
Primavera taxa 2025.pdf

open access

Type: versione editoriale
Size 6.74 MB
Format Adobe PDF
6.74 MB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie